Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

4183
Mitsui Chemicals, Inc. – TYO
Weekly Share Price & Valuation Overview
Market Overview
Open
3330.0000
Close
3355.0000
High
3384.0000
Low
3301.0000
Trend
0.47228

Mitsui Chemicals, Inc.

Japan • TYO - Tokyo Stock Exchange • 4183 • Currency: JPY

Mitsui Chemicals, Inc. engages in the mobility, life and health care, basic and green materials, ICT, and other businesses worldwide. The company offers vision care materials, nonwoven fabrics and personal care materials, agricultural chemicals, and oral care materials; and elastomers, performance and polypropylene compounds, and other materials. It also provides semiconductor solutions, such as electronic component processing materials, optical materials, and lithium-ion battery materials; functional food packaging materials; imaging solutions, such as lens materials, materials for reflective films, and LCD and OLED sealing materials; battery material solutions; and converting solutions, including, heat sealants, barrier coating materials, and packaging adhesives. In addition, the company offers petrochemicals, which comprise ethylene, propylene, high- and low-density polyethylene; basic chemicals, such as phenol, bisphenol, acetone, isopropyl alcohol, methyl isobutyl ketone, purified terephthalic acid, PET resin, ethylene oxide and glycol, hydroquinone, meta/para-cresol, ammonia, urea, and melamine; and polyurethane raw materials, as well as develops DNA microarrays. Further, it provides life care solutions, such as ophthalmic lens materials, photochromic lens materials, coating materials, nonwovens, breathable films, filtration devise, acrylamide , methacrylamide, and synthetic pulp; agrochemical products, including insecticides, fungicides, herbicides, non-crop specialty chemicals, pet medication ingredients; and medical solutions, restoratives, adhesives, artificial teeth, denture materials, impression, digital equipment/materials, medical materials, genetic testing, and contract genetic analysis services. It sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.

Potential weaknesses
  • Debt/EBITDA >4 — elevated leverage vs earnings capacity.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
Market Cap Total equity value of the company (share price × shares outstanding).
JPY 673.12B
Enterprise Value Operating value: market cap + total debt − cash.
JPY 1.37T
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
JPY 1.78T
Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
JPY 382.26B
EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
JPY 179.23B
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
JPY 9.42K
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
170.67
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
4.17%
Shares Outstanding
187.34M
Float Shares
174.52M
Implied Shares Outstanding
188.68M
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
2.02%
EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
10.10%
Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
21.53%
Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
0.85%
ROA Return on assets: net income ÷ total assets.
2.26%
ROE Return on equity: net income ÷ shareholder equity.
2.86%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Year-over-year revenue growth.
-7.60%
Earnings Growth (YoY) Year-over-year earnings growth.
-95.90%
Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-95.90%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Liquid current assets ÷ current liabilities (ex-inventory).
0.83
Debt to Equity Total debt ÷ shareholder equity; leverage.
0.79
Total Cash Cash and equivalents.
JPY 180.51B
Total Debt Short + long-term interest-bearing debt.
JPY 749.27B
Net Debt Total debt − cash (negative = net cash).
JPY 568.76B
Debt / EBITDA Leverage relative to operating earnings; lower is safer.
4.18
Cash Flow Shown only when internally consistent; margins are TTM.
Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
JPY 206.13B
Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
JPY 76.79B
OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
11.61%
FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
4.33%
Cash Conversion (OpCF/EBITDA)
1.15
Sharemaestro House View
Risk: 1 Sharemaestro internal risk profile (0–3, higher is safer). Operational: 2 Operational quality/consistency (0–3, higher is better). Composite Score: 1 Overall internal composite (0–3, higher is better). Suggested Allocation: 1.67% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading. 93.2%
Insiders Shares held by company insiders (officers, directors). 6.7%
Institutions Shares held by institutions (funds, pensions). 44.1%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
0.7%
Net Debt Total debt − cash (negative = net cash).
JPY 568.76B
32.0% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 33
Methodology Notes
  • Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
  • Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:07

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

AI generated insights not available yet. Sign in to generate the snapshot.